433.Sec. 14 - NEW

433.Sec. 14. NEW

1. The director of a public or private mental health facility or a psychiatrist designated by the director shall conduct a review of a recommendation to approve or deny a request for the involuntary administration of psychotropic medication made by a committee pursuant to section 13 of this regulation not later than 24 working hours after receiving the recommendation. In reviewing the recommendation, the director must consider, without limitation, the medical record of the patient and any other document reviewed by the committee. The director may also:

(a) Interview any person whom the director or his or her designee believes may have relevant information; and

(b) Conduct an examination of the patient.

2. During the review conducted by the director or his or her designee, the director or his or her designee shall consider:

(a) Whether the committee followed the proper procedures;

(b) Whether the proposed psychotropic medication is medically appropriate for the patient based on the diagnosis and medical history of the patient;

(c) Any stated objections of the patient to the administration of the medication; and

(d) Any other factor deemed relevant.

3. After conducting a review pursuant to this section, the director or his or her designee may:

(a) Require the involuntary administration of psychotropic medication to the patient in the manner requested by the practitioner with the primary responsibility for treating the patient;

(b) Require the involuntary administration of psychotropic medication to the patient in the manner determined appropriate by the director or his or her designee; or

(c) Prohibit the involuntary administration of psychotropic medication to the patient.

4. If the director or his or her designee requires the involuntary administration of psychotropic medication to a patient pursuant to subsection 3, the medication may be administered involuntarily to the patient for not more than 30 days. If the practitioner who is primarily responsible for treating the patient determines that it is necessary to continue administering medication to the patient for more than 30 days, the practitioner must request the consent of the patient. If the patient refuses to provide consent to continued administration of the medication, the practitioner must submit another request to involuntarily administer psychotropic medication pursuant to section 10 of this regulation.

Added to NAC by Div. of Men. Health & Dev. Services by R012-20A, eff. 8-26-2020

NRS 433.324

The following state regulations pages link to this page.